REZAMID (Summers Laboratories Inc)


Welcome to the PulseAid listing for the REZAMID drug offered from Summers Laboratories Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Summers Laboratories Inc
NON-PROPRIETARY NAME: SULFUR AND RESORCINOL
SUBSTANCE NAME: SULFUR; RESORCINOL
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: LOTION
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2013-10-30
END MARKETING DATE: 0000-00-00


REZAMID HUMAN OTC DRUG Details:

Item DescriptionREZAMID from Summers Laboratories Inc
LABELER NAME: Summers Laboratories Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 5; 2(g/100mL; 1/100mL)
START MARKETING DATE: 2013-10-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 11086-022_e078c7cb-46c4-4523-8f14-c6f4659ee352
PRODUCT NDC: 11086-022
APPLICATION NUMBER: part333D

Other SULFUR; RESORCINOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Halogent, LLC (DBA Exposed Skin Care)CLARIFYING MASK
Reckitt Benckiser LLCClearasil
Summers Laboratories IncREZAMID